About Us
The Health Thread
Ethical Health Journalism
Live
🌍Building Trust: Community Dialogues Boost Ebola Response in DRC🌍Rohingya Camps Face Health Crisis as Funding Shortfalls Threaten Essential Services in Cox's Bazar🌍Sudan Boosts Ebola Readiness Amid Regional Health Concerns🌍EU Pledges €12 Million to WHO for Syria's Vital Health System Revival🌍Uganda's Rapid Ebola Response: From Weeks to Hours, Saving Lives🌍Building Trust: Community Dialogues Boost Ebola Response in DRC🌍Rohingya Camps Face Health Crisis as Funding Shortfalls Threaten Essential Services in Cox's Bazar🌍Sudan Boosts Ebola Readiness Amid Regional Health Concerns🌍EU Pledges €12 Million to WHO for Syria's Vital Health System Revival🌍Uganda's Rapid Ebola Response: From Weeks to Hours, Saving Lives
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.

Researchers

Yasir Alayed, Andrew Loblaw, Lucas C Mendez, Rohann J M Correa, Aneesh Dhar, David Laidley, Andrew Warner, Hatim Fakir, Matt Wronski, John Conyngham, Zahra Kassam, Joelle Helou, David P D'Souza, Vikram Velker, Michael Lock, Belal Ahmad, Glenn S Bauman

Abstract

ARGOS-CLIMBER is a phase 1/2 trial evaluating PSMA PET and MRI guided prostate SABR with a simultaneous boost to intraprostatic and nodal disease in men with unfavourable intermediate and high-risk prostate cancer. The updated results demonstrate acceptable safety and quality of life with high biochemical and imaging response rates.
Source: PubMed (PMID: 42744076)View Original on PubMed